<rst>
<header>
	<relations>
			<rel name="means" type="rst"/>
			<rel name="elaboration" type="rst"/>
			<rel name="background" type="rst"/>
			<rel name="circumstance" type="rst"/>
			<rel name="condition" type="rst"/>
			<rel name="attribution" type="rst"/>
			<rel name="concession" type="rst"/>
			<rel name="purpose" type="rst"/>
			<rel name="restatement" type="rst"/>
			<rel name="evidence" type="rst"/>
			<rel name="preparation" type="rst"/>
			<rel name="sequence" type="multinuc"/>
			<rel name="same_unit" type="multinuc"/>
			<rel name="contrast" type="multinuc"/>
			<rel name="joint" type="multinuc"/>
		</relations>
</header>
<body>
<segment id="1" parent="1001" relname="preparation">2.</segment>
<segment id="2" parent="1002" relname="preparation">Typical Ligands for Bile Acids</segment>
<segment id="3" parent="1003" relname="preparation">BA targeted therapy is based on their receptors and ligands .</segment>
<segment id="4" parent="1005" relname="span">The regulation of BAs on other pathways occurs mainly through the activation of nuclear hormone receptors</segment>
<segment id="5" parent="4" relname="elaboration">( NHRs )</segment>
<segment id="6" parent="1007" relname="span">such as the farnesoid X receptor</segment>
<segment id="7" parent="6" relname="elaboration">( FXR ) ,</segment>
<segment id="8" parent="1009" relname="span">pregnane X receptor</segment>
<segment id="9" parent="8" relname="elaboration">( PXR ) , and vitamin D receptor</segment>
<segment id="10" parent="1009" relname="elaboration">( VDR ) .</segment>
<segment id="11" parent="1011" relname="span">For the activation of these receptors , it is necessary that they interact with the retinoid X receptor as a heterodimer</segment>
<segment id="12" parent="11" relname="elaboration">( RXR ) .</segment>
<segment id="13" parent="1013" relname="span">Afterwards , they act on various regulatory regions</segment>
<segment id="14" parent="1014" relname="span">by binding to hormone response elements</segment>
<segment id="15" parent="14" relname="elaboration">causing several genes to be up or downregulated in their transcription .</segment>
<segment id="16" parent="1017" relname="span">Most BAs and the secondary BA , and LCA , are binding to FXR and PXR respectively .</segment>
<segment id="17" parent="16" relname="elaboration">2.1 .</segment>
<segment id="18" parent="1019" relname="preparation">FXR</segment>
<segment id="19" parent="1019" relname="span">FXR plays an important role in BA , glucose , and lipid metabolism .</segment>
<segment id="20" parent="1020" relname="span">It is most highly expressed in the liver , ileum , kidneys , and adrenal glands .</segment>
<segment id="21" parent="1022" relname="span">The strongest activator is CDCA ,</segment>
<segment id="22" parent="21" relname="elaboration">followed by DCA , CA , and LCA .</segment>
<segment id="23" parent="1025" relname="span">Despite the fact</segment>
<segment id="24" parent="23" relname="elaboration">that LCA is a weak activator of FXR ,</segment>
<segment id="25" parent="1026" relname="joint">it is a very strong downregulator of its function</segment>
<segment id="26" parent="1026" relname="joint">and thus could be termed a partial agonist .</segment>
<segment id="27" parent="1027" relname="span">Controlling the synthesis and enterohepatic circulation of BAs , represents the major function of FXR .</segment>
<segment id="28" parent="1028" relname="span">In the liver , bile flow is prompted through FXR activation .</segment>
<segment id="29" parent="1030" relname="span">After being activated through BA in the ileum , the expression of fibroblast growth factor 15/19</segment>
<segment id="30" parent="29" relname="restatement">( FGF15/19 ) increases ,</segment>
<segment id="31" parent="1032" relname="span">leading to an activation of fibroblast growth factor receptor 4</segment>
<segment id="32" parent="31" relname="restatement">( FGFR4 )</segment>
<segment id="33" parent="1031" relname="same_unit">in hepatocytes (</segment>
<segment id="34" parent="1034" relname="preparation">Figure 1</segment>
<segment id="35" parent="1034" relname="joint">) .</segment>
<segment id="36" parent="1036" relname="span">This is of great importance</segment>
<segment id="37" parent="1038" relname="span">as FGF15/19 is an ileum-derived enterokine</segment>
<segment id="38" parent="37" relname="elaboration">that governs BA homeostasis , regulates hepatic glucose metabolism ,</segment>
<segment id="39" parent="1037" relname="joint">and stimulates protein synthesis .</segment>
<segment id="40" parent="1041" relname="condition">If administered pharmacologically or expressed transgenically in mice ,</segment>
<segment id="41" parent="1041" relname="joint">FGF19 increases hepatic lipid oxidation , reduces lipogenesis</segment>
<segment id="42" parent="1041" relname="joint">and protects from hepatosteatosis .</segment>
<segment id="43" parent="1043" relname="preparation">A lack of it causes impaired liver regeneration .</segment>
<segment id="44" parent="1045" relname="span">A lack of FGF 15 results in increased hepatic steatosis and in the development of endoplasmic reticulum</segment>
<segment id="45" parent="44" relname="restatement">( ER )</segment>
<segment id="46" parent="1046" relname="span">stress in the liver of mice</segment>
<segment id="47" parent="46" relname="elaboration">fed a high fat diet .</segment>
<segment id="48" parent="1049" relname="span">The activation of FGFR4 together with the activation of small heterodimer partner</segment>
<segment id="49" parent="48" relname="restatement">( SHP )</segment>
<segment id="50" parent="1048" relname="same_unit">in the liver , inhibits CYP7A1 .</segment>
<segment id="51" parent="1043" relname="joint">In order to downregulate CYP7A1 , intestinal-specific FXR is required .</segment>
<segment id="52" parent="1051" relname="sequence">On the other hand , the liver-specific FXR plays an important role in the repression of the expression of CYP8B1 .</segment>
<segment id="53" parent="1052" relname="joint">One of the mechanisms for BAs to suppress their own synthesis is through FXR .</segment>
<segment id="54" parent="1054" relname="span">FXR influences the hepatic lipid homeostasis via SHP ,</segment>
<segment id="55" parent="54" relname="elaboration">which reduces the expression of SREBP1 .</segment>
<segment id="56" parent="1056" relname="span">It also regulates the expression of peroxisome proliferator-activated receptor PPAR-α , a regulator of triglyceride metabolism ,</segment>
<segment id="57" parent="56" relname="elaboration">that can induce free fatty acid β-oxidation .</segment>
<segment id="58" parent="1052" relname="joint">2.2 .</segment>
<segment id="59" parent="1059" relname="span">Takeda G-Protein-Coupled Receptor 5</segment>
<segment id="60" parent="59" relname="elaboration">( TGR5 )</segment>
<segment id="61" parent="1061" relname="span">TGR5 is a G-protein coupled membrane receptor</segment>
<segment id="62" parent="61" relname="elaboration">that BAs activate .</segment>
<segment id="63" parent="1060" relname="joint">LCA is considered to be the strongest activator of TGR5 among the main primary and secondary BAs .</segment>
<segment id="64" parent="1064" relname="span">It is widely expressed in the body ,</segment>
<segment id="65" parent="1066" relname="span">for example in the gallbladder , ileum , colon , liver</segment>
<segment id="66" parent="65" relname="elaboration">( not in hepatocytes though ) ,</segment>
<segment id="67" parent="1067" relname="span">brown adipose tissue</segment>
<segment id="68" parent="67" relname="elaboration">( BAT ) , nervous system , and muscle .</segment>
<segment id="69" parent="1060" relname="joint">Besides being involved in BA , glucose , and lipid metabolism , interestingly ,</segment>
<segment id="70" parent="1060" relname="joint">it also plays a role in increasing the induction of BAT expression in thermogenesis and energy release via browning of white adipose tissue and .</segment>
<segment id="71" parent="1060" relname="joint">TGR5 knockout leads to a changed BA composition</segment>
<segment id="72" parent="1072" relname="span">and has anti-inflammatory properties</segment>
<segment id="73" parent="1074" relname="span">by for example by inhibiting nuclear factor kappa-light-chain-enhancer of activated B cells</segment>
<segment id="74" parent="73" relname="restatement">( NF-κB )</segment>
<segment id="75" parent="1073" relname="contrast">or LPS-induced production of inflammatory cytokines in macrophages .</segment>
<segment id="76" parent="1060" relname="joint">In another experiment , TGR5 knockout mice received a sleeve gastrectomy</segment>
<segment id="77" parent="1077" relname="attribution">and it was shown</segment>
<segment id="78" parent="1077" relname="span">how TGR5 is important</segment>
<segment id="79" parent="1078" relname="joint">in order to decrease hepatic steatosis , improve glucose control ,</segment>
<segment id="80" parent="1078" relname="joint">and increase the energy expenditure post-surgery .</segment>
<group id="1000" type="span" />
<group id="1001" type="span" parent="1000" relname="span"/>
<group id="1002" type="span" parent="1001" relname="span"/>
<group id="1003" type="span" parent="1002" relname="span"/>
<group id="1004" type="multinuc" parent="1010" relname="background"/>
<group id="1005" type="span" parent="1004" relname="same_unit"/>
<group id="1006" type="multinuc" parent="1004" relname="same_unit"/>
<group id="1007" type="span" parent="1006" relname="same_unit"/>
<group id="1008" type="span" parent="1006" relname="same_unit"/>
<group id="1009" type="span" parent="1008" relname="span"/>
<group id="1010" type="multinuc" parent="1003" relname="span"/>
<group id="1011" type="span" parent="1010" relname="joint"/>
<group id="1013" type="span" parent="1010" relname="joint"/>
<group id="1014" type="span" parent="13" relname="means"/>
<group id="1016" type="multinuc" parent="1010" relname="joint"/>
<group id="1017" type="span" parent="1016" relname="sequence"/>
<group id="1018" type="span" parent="1016" relname="sequence"/>
<group id="1019" type="span" parent="1018" relname="span"/>
<group id="1020" type="span" parent="19" relname="evidence"/>
<group id="1021" type="span" parent="20" relname="evidence"/>
<group id="1022" type="span" parent="1021" relname="span"/>
<group id="1023" type="span" parent="1022" relname="concession"/>
<group id="1024" type="span" parent="1023" relname="span"/>
<group id="1025" type="span" parent="1026" relname="concession"/>
<group id="1026" type="multinuc" parent="1024" relname="span"/>
<group id="1027" type="span" parent="1024" relname="evidence"/>
<group id="1028" type="span" parent="27" relname="evidence"/>
<group id="1029" type="span" parent="28" relname="evidence"/>
<group id="1030" type="span" parent="1031" relname="circumstance"/>
<group id="1031" type="multinuc" parent="1029" relname="span"/>
<group id="1032" type="span" parent="1031" relname="same_unit"/>
<group id="1033" type="span" parent="1010" relname="joint"/>
<group id="1034" type="multinuc" parent="1033" relname="span"/>
<group id="1036" type="span" parent="1034" relname="joint"/>
<group id="1037" type="multinuc" parent="36" relname="circumstance"/>
<group id="1038" type="span" parent="1037" relname="joint"/>
<group id="1040" type="span" parent="1034" relname="joint"/>
<group id="1041" type="multinuc" parent="1040" relname="span"/>
<group id="1042" type="span" parent="1034" relname="joint"/>
<group id="1043" type="multinuc" parent="1042" relname="span"/>
<group id="1044" type="multinuc" parent="1043" relname="joint"/>
<group id="1045" type="span" parent="1044" relname="same_unit"/>
<group id="1046" type="span" parent="1044" relname="same_unit"/>
<group id="1048" type="multinuc" parent="1043" relname="joint"/>
<group id="1049" type="span" parent="1048" relname="same_unit"/>
<group id="1051" type="multinuc" parent="1043" relname="joint"/>
<group id="1052" type="multinuc" parent="1051" relname="sequence"/>
<group id="1054" type="span" parent="1052" relname="joint"/>
<group id="1056" type="span" parent="1052" relname="joint"/>
<group id="1058" type="span" parent="1052" relname="joint"/>
<group id="1059" type="span" parent="1060" relname="preparation"/>
<group id="1060" type="multinuc" parent="1058" relname="span"/>
<group id="1061" type="span" parent="1060" relname="joint"/>
<group id="1064" type="span" parent="1060" relname="joint"/>
<group id="1065" type="multinuc" parent="64" relname="purpose"/>
<group id="1066" type="span" parent="1065" relname="same_unit"/>
<group id="1067" type="span" parent="1065" relname="same_unit"/>
<group id="1072" type="span" parent="1060" relname="joint"/>
<group id="1073" type="multinuc" parent="72" relname="means"/>
<group id="1074" type="span" parent="1073" relname="contrast"/>
<group id="1076" type="span" parent="1060" relname="joint"/>
<group id="1077" type="span" parent="1076" relname="span"/>
<group id="1078" type="multinuc" parent="78" relname="purpose"/>
	</body>
</rst>
